BFC Planning’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$325 Sell
6
-347
-98% -$15.6K ﹤0.01% 3326
2026
Q2
$14.8K Sell
353
-294
-45% -$9.36K ﹤0.01% 2158
2026
Q1
$17.1K Hold
647
– – ﹤0.01% 1780
2025
Q4
$18.7K Hold
647
– – ﹤0.01% 1775
2025
Q3
$18K Hold
647
– – ﹤0.01% 1626
2025
Q2
$15.8K Sell
647
-100
-13% -$2.19K ﹤0.01% 1604
2025
Q1
$15.5K Buy
747
+100
+15% +$2.51K ﹤0.01% 1580
2024
Q4
$15.2K Hold
647
– – ﹤0.01% 1570
2024
Q3
$16.6K Buy
+647
New +$16.5K ﹤0.01% 1532

Other funds holding ARKG

BFC Planning's ARKG Position: Q3 2026 in Review

BFC Planning reduced its ARK Genomic Revolution ETF (ARKG) stake by 98% in Q3 2026, selling an estimated $15.6K and leaving 6 shares worth $325. The position accounts for ﹤0.01% of the portfolio, ranked #3326.

BFC Planning first reported a position in ARKG in Q3 2024 and has held it in 9 quarters since. The position peaked at $18.7K in Q4 2025. 260 funds tracked by Wall St. Rank hold ARKG as of Q3 2026.

  • BFC Planning held 6 shares of ARK Genomic Revolution ETF worth $325 as of Q3 2026.
  • BFC Planning sold 347 ARK Genomic Revolution ETF shares in Q3 2026, an estimated $15.6K.
  • ARK Genomic Revolution ETF made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3326 holding.
  • BFC Planning first reported a position in ARK Genomic Revolution ETF in Q3 2024 and has held it in 9 quarters since.
  • BFC Planning's ARK Genomic Revolution ETF position peaked at $18.7K in Q4 2025.
  • 260 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q3 2026.

Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.